Écrit par GBI research | 21 Juin 2012

NEW YORK (GBI Research), 21 June 2012 - Argentina is boosting the health of their citizens thanks to strong government schemes that are providing medical attention to those that need it, while financially supporting the country’s in-house pharmaceutical production, according to a new report from healthcare experts GBI Research.

The new report shows that the Argentine pharmaceutical market...

Écrit par GlobalData | 20 Juin 2012

LONDON, UK (GlobalData), 20 June 2012 - European healthcare is being transformed as a result of economic recession, as austerity measures reshape the way that countries run, states a new report by healthcare experts GlobalData.

The new report* looks at the sovereign debt crisis, formed by a collection of budget deficits created by insufficient tax revenue and excessive spending in across...

Écrit par Pluristem Therapeutics | 19 Juin 2012

HAIFA, ISRAEL – June 19, 2012 -- Pluristem Therapeutics, Inc. (NASDAQCM:PSTI; TASE: PLTR) announced today at the 2012 Bio International Convention the results of a pre clinical study it conducted measuring the effectiveness of its Placental eXpanded (PLX) cells when administered intramuscularly(IM). Cell therapies are traditionally delivered through intravenous (IV) injections for...

Écrit par GBI Research | 14 Juin 2012

NEW YORK (GBI Research), 14 June 2012 - The global market for biosimilar drugs is due to come under attack from popular generic drugs, as governments fight to control rising healthcare expenditure, according to healthcare experts GBI Research.

The new report* states that governments in emerging economies are struggling to match the soaring demand for cheaper drugs, due to an increase in...